Many institutions now cover OA publishing costs for affiliated researchers, as part of an OA agreement with Springer Nature. Find out more about OA agreements and whether you may be entitled to publish OA with your fees covered.
Check your eligibility to publish open access with your fees covered
- World Aids Day
- Retroviruses & the Microbiome
- The multifaceted regulation of transcription in animal and human retroviruses, endogenous retroviruses
- HIV infection of uncommon host cells
- Applications of CRISPR-Cas and genome editing techniques for established and emerging infectious diseases
- Previous Thematic Series
December 1st marks World AIDS Day, a globally recognized occasion dedicated to raising awareness of the AIDS pandemic and mourning those we have lost.
This cross-journal collection focuses on exploring the effects and consequences of long-term HIV infection, advances in treatment, epidemiological studies and global health, and more.
The focus of this issue is to move beyond associations to mechanisms and functional interactions, including both replication-competent and endogenous retroviruses, human and non-human hosts, and implications for homeostasis, disease and/or therapeutics.
Deadline for submissions: 31st March 2024
The multifaceted regulation of transcription in animal and human retroviruses, endogenous retroviruses
Retroviruses are enveloped viruses with a capsid containing two copies of the viral genomic positive sense single-stranded RNA. Retroviruses are responsible for a broad range of diseases in animals and humans, the most common of which is the development of cancers.
This collection aims to provide a state of the art critical evaluation of HIV infection of atypical cells, their role in pathogenesis and the challenges that they might present when developing and evaluating approaches towards an HIV cure.
Applications of CRISPR-Cas and genome editing techniques for established and emerging infectious diseases
The simplicity and broad applicability of targeted and programmable genome editing approaches, including but not limited to those based on CRISPR-Cas9, raise the possibility of a new way to treat a variety of infections, as well as numerous therapeutic strategies for common diseases. This series aims to build a collection of articles that will highlight current developments in this area.
Previous Thematic Series
The Capsid Protein, a Master Regulator of HIV-1 Replication
Edited by Felipe Diaz-Griffero
HIV Intervention Using Mouse Models for Viruses
Edited by J Victor Garcia-Martinez and Angela Wahl
Endogenous Retroviruses in Evolution and Disease
HTLV-1: a re-emerging human pathogen
Edited by Genoveffa Franchini and Cynthia Masison
Broadly neutralizing antibodies (bnAbs) against HIV
Edited by Rogier Sanders and Marit van Gils
Measuring HIV-1 persistence in vivo
Edited by Ben Berkhout and Alexander Pasternak
Disruptive technologies in retrovirus research
Edited by Johnson Mak
From the blog
01 December 2023
14 January 2022
Announcing the launch of In Review
Retrovirology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Nominations for the Best Retrovirology Paper by a Young Scientist Award are now open
Nominations for the Best Retrovirology Paper by a Young Scientist Award are now open until March 6th. Read more about eligibility criteria and how to nominate colleagues at the below webpage.Read More
KT Jeang Retrovirology Prize 2023
Johnson Mak, PhD, Institute for Glycomics, Griffith University, Australia
Susan Ross, University of Illinois at Chicago, USA
Andrew Lever, PhD, University of Cambridge (Emeritus Professor), UK
Kuan-Teh Jeang, MD, PhD, National Institutes of Health, USA (1958-2013)
Why publish your article in Retrovirology?
- We welcome research from across the entire field of retroviruses, supporting the research community with a progressive and inclusive approach.
- Ranked among the top virology journals worldwide, we publish high quality research and expert reviews across basic science, translational, and clinical research.
- Our expert and highly responsive team of Editors provides excellent service throughout, with rapid evaluation and publication of research with broad and lasting impact.
- Founded in 2004, we are one of the leading influencers in HIV/AIDS and retrovirus research, reaching a large global audience.
Aims and scope
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on host-pathogen interactions, fundamental mechanisms of replication, immune defenses, animal models, and clinical science relating to retroviruses. Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses.
Two human retroviruses are especially important pathogens. These are the human immunodeficiency virus, HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-1 is the etiological agent for adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology aims to cover comprehensively all aspects of human and animal retrovirus research.
Johnson Mak, Editor-in-Chief
Professor Mak is a native of Hong Kong who undertook his undergraduate and post-graduate training at McGill University in Montreal, Canada. During his PhD Johnson worked with Professor Lawrence Kleiman at the McGill AIDS Centre studying packaging of primer tRNA into HIV. He subsequently moved to Melbourne, Australia to continue work on HIV assembly at the Burnet Institute under the guidance of Professor Suzanne Crowe. He is currently a Professor at the Institute for Glycomics, Griffith University, Gold Coast. He has a broad research portfolio in HIV having studied primer tRNAs in retroviruses, genomic RNA packaging and dimerization, cholesterol and lipids in HIV, viral-host interactions, imaging of HIV and analysis of recombination and mutation in HIV using next generation sequencing. His team pioneered the production of full-length recombinant HIV Gag for biochemical and biophysical analyses of HIV assembly. Recently Johnson and his team have described a pre-entry priming process for HIV.
Susan Ross, Editor-in-Chief
Susan R. Ross, PhD is Sweeney Basic Sciences Professor of and Head of the Department of Microbiology and Immunology at the UIC College of Medicine. Dr. Ross's research interests are in the genetics of host-virus interactions, particularly retroviruses and new world arenaviruses. Dr. Ross was on the faculty in Biochemistry at UIC from 1983-94. In 1994, she moved to the Microbiology Department at the University of Pennsylvania, where she also served as Associate Dean for Biomedical Graduate Studies from 2002-12. In 2015, she moved to UIC to assume the Head position.
Dr. Ross has served on numerous review panels and editorial boards, including the Recombinant DNA Advisory Committee of the NIH, Senior Editor for the Journal of Virology, Section Editor of PLOS Pathogens and on the Editorial Committee of the Annual Review of Virology. Dr. Ross has received several awards for teaching and research, including the ASM Wellcome Visiting Professorship, the ASM International Professorship and the Center for Retrovirus Research Distinguished Research Career Award (Ohio State University). Dr. Ross was elected a Fellow of the American Academy of Microbiology in 2002 and an AAAS Fellow in 2009.
Annual Journal Metrics
2022 Citation Impact
3.3 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.004 - SNIP (Source Normalized Impact per Paper)
0.892 - SJR (SCImago Journal Rank)
7 days submission to first editorial decision for all manuscripts (Median)
94 days submission to accept (Median)
1,868 Altmetric mentions